Cisatracurium Besylate
NDC 55150-284, Cisatracurium Besylate, injection, from Eugia US LLC.
- Product NDC
- 55150-284
- Status
- Listed
- Labeler
- Eugia US LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209665
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55150-284 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CISATRACURIUM BESYLATE10 mg/5mL
Pharmacologic classes
Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55150-284-10 | 55150028410 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-284-10) / 5 mL in 1 VIAL, SINGLE-DOSE (55150-284-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2cb05c7e-6228-4e2d-a270-7659e3db3fa7
Use it
Look up 55150-284 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55150-284 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55150-284. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.